Sponsor
Population Health Research Institute
Clinical research sponsor
Clinical trials
31 shownSurgical Ablation of AF Efficacy TrialNCT05434819 · lead sponsor · 2023-06-01
RECRUITINGReducing Mortality in Adults With Advanced HIV Disease (REVIVE)NCT05580666 · lead sponsor · 2023-05-08
RECRUITINGVIrtual Care To Improve Outcomes and RecoverY From Heart Failure HospitalizationNCT05724433 · lead sponsor · 2023-01-23
RECRUITINGSafety of Continuing HER-2 Directed Therapy in Overt Left Ventricular DysfunctionNCT04680442 · lead sponsor · 2021-07-01
RECRUITINGProspective Urban Rural Epidemiology StudyNCT03225586 · lead sponsor · 2002-01-01
RECRUITINGLeft Atrial Appendage Occlusion Study III Extended Follow UpNCT05399342 · lead sponsor · 2022-07-01
WITHDRAWNRemission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLiraNCT03862716 · lead sponsor · 2019-04-23
COMPLETEDPeriOperative ISchemic Evaluation-3 TrialNCT03505723 · lead sponsor · 2018-06-27
COMPLETEDPrevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital ReadmissionNCT03541616 · lead sponsor · 2018-03-24
COMPLETEDRemission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixiNCT03130426 · lead sponsor · 2017-06-27
COMPLETEDSafety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2NCT02907021 · lead sponsor · 2016-11-01
COMPLETEDRemission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Sitagliptin (REMIT-Sita)NCT02623998 · lead sponsor · 2016-07-09
COMPLETEDRemission Evaluation of a Metabolic Intervention in Type 2 Diabetes With ForxigaNCT02561130 · lead sponsor · 2015-12-01
COMPLETEDHome-Based Screening for Early Detection of Atrial Fibrillation in Primary Care Patients Aged 75 Years and OlderNCT02392754 · lead sponsor · 2015-04-01
COMPLETEDPatient-centered Care Transitions in Heart Failure: A Pragmatic Cluster Randomized TrialNCT02112227 · lead sponsor · 2015-03-01
COMPLETEDPrevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop RecorderNCT02401854 · lead sponsor · 2014-01-01
COMPLETEDRemission Evaluation of Metabolic Interventions in Type 2 Diabetes (REMIT Pilot Trial)NCT01181674 · lead sponsor · 2011-01-01
COMPLETEDStudy of Health Assessment and Risk Evaluation in Aboriginal Peoples Action Toward Obesity Prevention (SHARE-AP Action)NCT00334269 · lead sponsor · 2004-05-01
COMPLETEDCOLchicine and Thiamine in Heart Failure Due to Ischemic Heart DiseaseNCT05873881 · collaborator · 2024-01-29
RECRUITINGThe ECLA/PHRI Intervention in the Community TrialNCT05638009 · collaborator · 2022-11-14
UNKNOWNA Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational DiabetesNCT03607799 · collaborator · 2020-11-26
ACTIVE_NOT_RECRUITINGBariatric Surgery for the Reduction of cArdioVascular Events Feasibility TrialNCT04226664 · collaborator · 2020-10-30
UNKNOWNMajor Outcomes With Personalized Dialysate TEMPeratureNCT02628366 · collaborator · 2017-04-03
COMPLETEDGlobal Congestive Heart Failure RegistryNCT03078166 · collaborator · 2016-12-20
COMPLETEDInfluenza Vaccine To Prevent Adverse Vascular Events:PilotNCT01945268 · collaborator · 2015-04-01
COMPLETEDHeart Outcomes Prevention and Evaluation 4NCT01826019 · collaborator · 2014-08-01
COMPLETEDAssessment of Bioimpedance and Vitamin D and LV Mass in PD Patients (FLUID Study)NCT01045980 · collaborator · 2010-08-01
COMPLETEDStudy to Compare 2 Doses of Polycap Versus Single Dose of Polycap With or Without PottasiumNCT01404078 · collaborator · 2010-04-01
COMPLETEDThiazolidinedione Intervention With Vitamin D EvaluationNCT00879970 · collaborator · 2009-05-01
TERMINATEDAsymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing TrialNCT00256152 · collaborator · 2004-09-01
COMPLETEDThe ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)NCT00069784 · collaborator · 2003-08-01
COMPLETEDSponsor roles
lead sponsor18
collaborator13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.